Form 8-K - Current report:
SEC Accession No. 0000950170-22-010765
Filing Date
2022-05-26
Accepted
2022-05-26 16:11:25
Documents
12
Period of Report
2022-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20220526.htm   iXBRL 8-K 114925
  Complete submission text file 0000950170-22-010765.txt   231442

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20220526_lab.xml EX-101.LAB 12890
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20220526.xsd EX-101.SCH 2492
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20220526_pre.xml EX-101.PRE 9543
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20220526_htm.xml XML 4536
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 22970056
SIC: 2834 Pharmaceutical Preparations